The effect of the pandemic period on Bladder Pain Syndrome patients under amitriptyline treatment

被引:2
|
作者
Sahin, Mehmet Fatih [1 ,5 ]
Ozcan, Ridvan [2 ]
Malak, Arzu [3 ]
Dogan, Cagri [4 ]
Yazici, Cenk Murat [4 ]
Ozcan, Muege [4 ]
Akgul, Murat [4 ]
机构
[1] Corlu State Hosp, Dept Urol, Corlu, Tekirdag, Turkiye
[2] Bursa City Hosp, Dept Urol, Bursa, Nilufer, Turkiye
[3] Tekirdag Namik Kemal Univ, Sch Hlth, Nursing Dept, Suleymanpasa, Tekirdag, Turkiye
[4] Tekirdag Namik Kemal Univ, Med Sch, Dept Urol, Suleymanpasa, Tekirdag, Turkiye
[5] Corlu State Hosp, Dept Urol, TR-59850 Corlu, Tekirdag, Turkiye
关键词
anxiety; bladder pain syndrome; COVID-19; depression; INTERSTITIAL CYSTITIS; ANXIETY; WOMEN;
D O I
10.1002/nau.25199
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
IntroductionCOVID-19 is a disease that may cause anxiety, depression, and stress. Bladder pain syndrome (BPS) is a disease in which stress and psychological factors might negatively affect its course. In this study, we aimed to examine the possible clinical aggregation of the pandemic period on BPS patients. Materials and MethodsA total of 35 BPS patients diagnosed between 2010 and 2018 were included. All patients were using medical treatment, and the follow-up period was at least 6 months. According to our clinical follow-up protocol, the BPS patients were given the King's Health Questionnaire (KHQ), Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), Overactive Bladder Form V8 (OAB-V8), and Visual Analog Score (VAS) in every visit. In the sixth month of the pandemic, the clinical course of the patients was questioned by telephone or video interview, and their treatment continuities were questioned. Information was received about the delays in their follow-up and the difficulties in accessing healthcare opportunities. The same questionnaires were filled out and compared with pre-pandemic scores. ResultsThe mean age of the patients included in the study was 50.2 +/- 13.32 (min:20, max:74), 11 were males and 24 were females. The mean follow-up periods were 71.8 +/- 35.6 months. All questionnaire scores showed an increase compared to the pre-pandemic period. A statistically significant increase was detected during the pandemic in all sub-units of the KHQ. The VAS and OAB-V8 scores of 16 patients who requested hospital admission were significantly higher than before the pandemic. However, there was no statistically significant difference in the increase in VAS and OAB-V8 scores of the 19 patients who refused to come to the hospital. ConclusionBPS patients have been negatively affected by the emotional effects of the COVID-19 pandemic. Due to the fear, stress, anxiety, and depression, the symptoms of BPS patients exacerbated, and the patients could not receive the necessary support due to a lack of regular follow-ups.
引用
收藏
页码:1188 / 1193
页数:6
相关论文
共 50 条
  • [1] Effect of Amitriptyline on Symptoms in Treatment Naive Patients With Interstitial Cystitis/Painful Bladder Syndrome
    Foster, Harris E., Jr.
    Hanno, Philip M.
    Nickel, J. Curtis
    Payne, Christopher K.
    Mayer, Robert D.
    Burks, David A.
    Yang, Claire C.
    Chai, Toby C.
    Kreder, Karl J.
    Peters, Kenneth M.
    Lukacz, Emily S.
    FitzGerald, Mary P.
    Cen, Liyi
    Landis, J. Richard
    Propert, Kathleen J.
    Yang, Wei
    Kusek, John W.
    Nyberg, Leroy M.
    JOURNAL OF UROLOGY, 2010, 183 (05): : 1853 - 1858
  • [2] TREATMENT OF COMPLEX REGIONAL PAIN SYNDROME WITH AMITRIPTYLINE
    Komoly Samuel
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2019, 72 (7-8): : 279 - 281
  • [3] IMPACT OF AMITRIPTYLINE ON TREATMENT OF MYOFACIAL PAIN DYSFUNCTION SYNDROME
    Moras, Kuldeep
    Pinto, Veena
    Shivaraj, Rahul
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2014, 3 (51): : 11893 - 11897
  • [4] The role of bladder instillation in the treatment of bladder pain syndrome: Is intravesical treatment an effective option for patients with bladder pain as well as LUTS?
    Giuseppe Alessandro Digesu
    Visha Tailor
    Alka A. Bhide
    Vik Khullar
    International Urogynecology Journal, 2020, 31 : 1387 - 1392
  • [5] The role of bladder instillation in the treatment of bladder pain syndrome: Is intravesical treatment an effective option for patients with bladder pain as well as LUTS?
    Digesu, Giuseppe Alessandro
    Tailor, Visha
    Bhide, Alka A.
    Khullar, Vik
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2020, 31 (07) : 1387 - 1392
  • [6] The effect of intravesical cocktail therapy combined with low-dose amitriptyline on primary bladder pain syndrome
    Deniz Abat
    Adem Altunkol
    Fatih Gökalp
    International Urogynecology Journal, 2022, 33 : 1225 - 1230
  • [7] The effect of intravesical cocktail therapy combined with low-dose amitriptyline on primary bladder pain syndrome
    Abat, Deniz
    Altunkol, Adem
    Gokalp, Fatih
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2022, 33 (05) : 1225 - 1230
  • [8] Effect of amitriptyline in treatment interstitial cystitis or bladder pain syndrome according to two criteria: Does ESSIC criteria change the response rate?
    Sun, Yaofei
    Fang, Zujun
    Ding, Qiang
    Zheng, Jie
    NEUROUROLOGY AND URODYNAMICS, 2014, 33 (03) : 341 - 344
  • [9] Efficacy of Amitriptyline in Treatment-Naïve Patients with Interstitial Cystitis/Painful Bladder Syndrome
    Pontari M.
    Current Bladder Dysfunction Reports, 2010, 5 (4) : 175 - 176
  • [10] The effect of amitriptyline in female overactive bladder patients with nocturia
    Jeong, H. J.
    Park, S. C.
    Han, D. Y.
    Oh, S. J.
    Roh, J. H.
    Baek, S. H.
    Kim, S. O.
    Lee, J. H.
    Ryu, S. H.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2007, 18 : S133 - S133